Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib.

Aydiner, Adnan

Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib. [electronic resource] - Medicine Jun 2015 - e887 p. digital

Publication Type: Journal Article

1536-5964

10.1097/MD.0000000000000887 doi


Carcinoma, Non-Small-Cell Lung--drug therapy
Erlotinib Hydrochloride
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Retrospective Studies
Survival Rate
Treatment Outcome